Stay updated on Immunotherapy+IRE in Pancreatic Adenocarcinoma Clinical Trial

Sign up to get notified when there's something new on the Immunotherapy+IRE in Pancreatic Adenocarcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Immunotherapy+IRE in Pancreatic Adenocarcinoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The study contact information was updated: Marilyn Donaldson was removed as contact and Robert Martin, MD, PhD is now listed with updated phone and email. Primary Completion is now estimated for 2028-06-01 and Study Completion for 2029-04-01, and a new 'Last Update Posted (Estimated)' indicator was added.
    Difference
    1%
    Check dated 2025-11-03T13:19:36.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    32 days ago
    Change Detected
    Summary
    - Added a government funding lapse notice and operating-status guidance, and confirmed the NIH Clinical Center is open with sources. - Version updated from v3.1.0 to v3.2.0.
    Difference
    6%
    Check dated 2025-10-06T04:16:01.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    Updated page version to v3.1.0 and added a contact phone number (502-629-3323); previous version was v3.0.2.
    Difference
    0.1%
    Check dated 2025-09-28T23:38:12.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Updated the page revision from v3.0.1 to v3.0.2. The 'Back to Top' element was removed.
    Difference
    0.4%
    Check dated 2025-09-14T09:59:43.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.4%
    Check dated 2025-09-07T07:53:31.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, as well as various clinical and laboratory techniques related to proteins and antibodies. Notably, previous references to specific types of neoplasms and antineoplastic agents have been removed.
    Difference
    5%
    Check dated 2025-08-31T01:04:31.000Z thumbnail image

Stay in the know with updates to Immunotherapy+IRE in Pancreatic Adenocarcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Immunotherapy+IRE in Pancreatic Adenocarcinoma Clinical Trial page.